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Background: Refractory hypertension is defined as blood pressure that remains above 140/90 mmHg, 
despite the adherence to appropriate life style changes and the concurrent use of optimal doses of 3 
antihypertensive agents of different classes.1 Refractory hypertension has a worse prognosis than that 
of essential hypertension; a higher prevalence of subclinical organ damage can be found in patients 
with resistant hypertension.5 
Aim: The aim of the study is to investigate the effect of a homoeopathic complex containing Amylenum 
nitrosum 6cH, Crataegus oxyacantha 6cH, Natrum muriaticum 6cH and Scutellaria lateriflora 6cH on 
blood pressure in adults with refractory hypertension, by means of blood pressure readings. 
Method: Participants previously diagnosed with refractory hypertension were recruited by means of 
purposive sampling. The study was a six week, double-blind, placebo-controlled study. Participants 
were divided into two groups, namely: the treatment and placebo groups, which received 30ml identical 
amber glass bottles of either the placebo or the treatment remedy every week that looked, tasted and 
smelled the same. 
Results: Participants in both the groups showed a decline in blood pressure over the study period. The 
results indicated that there was no statistically significant difference in blood pressure readings 
between the two groups at any point in time. 
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Introduction 
Refractory hypertension ( Resistant high blood 
pressure) is a challenge both to health 
practitioners as well as to patients themselves, 
as high blood pressure (hypertension) remains 
one the most prominent of all health related 
problems in developed societies worldwide, 
and is associated with ever increasing  obesity 
rates.1 
Hypertension results in 7.6 million deaths 
annually and 92 million disability adjusted 
years worldwide, 2 and thus it is the number one 
determinable risk factor for mortality 
throughout the world.3 In Sub-Saharan Africa it 
is regarded as one of the greatest health 
challenges after human immunodeficiency 
virus infection (HIV) and acquired immune 
deficiency syndrome (AIDS).4 
 
Although hypertension is generally 
asymptomatic, it may however present with 
signs and symptoms relating to the cause in 
cases of secondary hypertension. Malignant 
hypertension may present with a headache and 
multiple neurological deficits such as stupor, 
sensory or motor disturbances.4 
 
Refractory hypertension has a worse prognosis 
than that of primary hypertension; a higher 
prevalence of subclinical organ damage can be 
found in patients with refractory hypertension, 
including left ventricular hypertrophy, 
hypertensive retinopathy, albuminuria and 
initial impairment of renal function.5 
 
Diagnosis of high blood pressure is made based 
on at least 3 different blood pressure readings 
taken on three consecutive days preferably at 
the same time of day. Special investigations are 
not routine, they are mostly performed in 
patients younger than 40 years of age and those 
presenting with severe or refractory 
hypertension (Beevers et al., 2007).1 
 
In hypertensive individuals, lifestyle 
modifications serve as initial therapy before the 
start of pharmacological therapy and as an 
adjunct to those already on drug therapy (Libby 
et al., 2010).6 
If after six months of lifestyle modification, 
systolic pressure remains >140 mmHg or 
diastolic blood pressure remains >90 mmHg 
antihypertensive drugs are required.7 
 
Refractory hypertension is then diagnosed 
when blood pressure remains above 140/90 
mmHg, despite the adherence to appropriate 
life style changes and the concurrent use of 
optimal doses of three antihypertensive agents 
of different classes, one being a diuretic. 
Patients whose blood pressure can be controlled 
only through the use of four or more 
antihypertensive medications are also said to 
have refractory hypertension.8 
 
There has been little research conducted on the 
effect of homoeopathic remedies on 
hypertension. One four-week, double-blind, 
placebo-controlled study on adult males with 
essential hypertension compared a 
homoeopathic complex containing: Viscum 
album 6cH, Crataegus oxyacantha 6cH, 
Rauwolfia serpentine 6cH, Lachesis mutans 
6cH, Natrium muriaticum 6cH and Veratrum 
album 6cH to a placebo. The homoeopathic 
complex produced a statistically significant 
greater decrease in blood pressure compared to 
placebo.9 
 
 A six-week, double-blind, placebo-controlled 
study using a homoeopathic complex 
containing Crataegus oxyacantha 6cH, Viscum 
album  6cH, Digitalis purpurea 6cH and 
Glonoine 6cH was conducted on 30 adult black 
participants from Gauteng South Africa with 
essential hypertension. There was also a 
statistically significant decrease in blood 
pressure in the treatment group compared to 
placebo.10 
 
A four week study was conducted to compare 
the efficacy of the homoeopathic simillimum 
and a homoeopathic complex (Aurum 
metallicum 6CH, Lachesis muta 6CH, Natrum 
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muriaticum 6CH, and Veratrum album 6CH) in 
the treatment of primary hypertension in adult 
females. There was a statistically significant 
decline in both diastolic and systolic blood 
pressures of both the groups on the 
homoeopathic treatment.11 
 
Another double-blind, randomized, placebo-
controlled study was conducted on 150 
participants. The aim was to evaluate whether 
individualized homoeopathy can produce any 
significant effect different from placebo in 
essential hypertension by comparing the 
lowering of blood pressure between groups. 
The outcome measures were assessed after 
three months and six months. Individualized 
homoeopathy produced a significantly different 
hypotensive effect than placebo.12 
 
The aim of the study is to investigate the effect 
of a homoeopathic complex containing 
Amylenum nitrosum 6cH, Crataegus 
oxyacantha 6cH, Natrum muriaticum 6cH and 
Scutellaria lateriflora 6cH on blood pressure in 
adults with refractory hypertension, by means 
of blood pressure readings. 
 
Material and Methods 
 
This study was conducted at the Homoeopathy 
health clinic at the University of Johannesburg 
Doornfontein Campus, and at Nanga Vutshilo 
(choose life) Community based Centre in 
Soweto, Gauteng. The study was approved by 
the University Johannesburg Faculty of Health 
Sciences Research Committee and was given 
the following clearance numbers, AEC-01-65-
2014 and HDC 01-64-2015. The study was also 
registered on the clinical Trial registry REC-
241112-035. Participation was voluntary and 
participants held the right to withdraw at any 
point without prejudice.  
 
 
 
 
 
Research sample and inclusion criteria 
 
Participants previously diagnosed with 
refractory hypertension were recruited by 
means of purposive sampling. Advertisement 
were placed at Nanga Vutshilo choose life 
Community based centre and at the 
homoeopathy health clinic at the University of 
Johannesburg. With relevant permission 
obtained and all consultations occurred under 
supervision of a qualified clinician. 
 
Participants were included in the study if they: 
were male or female, between the ages 35-65 
years; had a systolic blood pressure between  
140 mmHg-165 mmHg; had a diastolic blood 
pressure between 85 mmHg-95 mmHg; and 
Were on conventional anti-hypertensive 
medication (ACE-inhibitor or ARB’s, and/or 
diuretic, and /or calcium channel blocker). 
 
 Participants were excluded from the study if 
they: had a systolic blood pressure < 140 
mmHg; > 165 mmHg; had a diastolic blood 
pressure < 85 mmHg; > 95mmHg; were 
pregnant or lactating; were on any other herbal 
or homoeopathic medicine for the treatment of 
hypertension; Had secondary organ damage 
from hypertension; and Suffered from chronic 
conditions such as severe cardiac disease, renal 
failure, malignant hypertension or diabetes 
mellitus. 
 
Participants were requested not to make any 
changes to their diet or lifestyle and not to take 
any other medication (including herbal, 
homoeopathic or supplemental) for their 
hypertension for the duration of the study. All 
participants were also asked to continue with 
their prescribed medication for the duration of 
the study. 
 
Research design and procedure 
 
This study was a six week, double-blind, 
placebo-controlled study. Potential participants 
that responded to the advert attended an initial 
consultation and were requested to sign a 
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Participant Information and Consent Form. The 
medical history and physical examination 
(including vital signs, fundoscopic exam, 
cardiovascular exam, respiratory exam and 
urinalysis) were recorded on the Case Form. 
Blood pressure readings were taken on each 
arm with a manual BP cuff according to 
standard operating procedures. Those 
participants that qualified for the study were 
placed into two groups. One group received a 
30ml bottle of the homoeopathic complex and 
the other group a 30ml bottle of placebo. 
Follow-up consultations took place every week 
and participants were requested to bring with 
their medication bottles for assessment of 
compliance; BP readings were recorded on the 
data collection form. All participants were 
given the Dietary Approaches to Stop 
Hypertension (DASH) eating plan at the end of 
the study to help control their hypertension. 
 
Medication administration 
 
The medication was randomized by an 
independent person; both groups received 30ml 
identical amber glass bottles of either the 
placebo or the treatment remedy every week. 
The placebo (un-medicated alcohol) looked, 
tasted and smelled the same as the treatment 
medication (containing containing Amylenum 
nitrosum 6cH, Crataegus oxyacantha 6cH, 
Natrum muriaticum 6cH and Scutellaria 
lateriflora 6cH). Participants were instructed to 
take 10 drops, thrice daily under the tongue, 30 
minutes before or after meals, starting from day 
one. 
 
 Reliability and Validity  
 
The homoeopathic complex and the placebo 
was supplied by a registered homoeopathic 
laboratory (Comed); a qualified dispenser 
prepared the complex according to the method 
laid out in the German Homoeopathic 
Pharmacopoeia.13 Comed laboratory follows 
the South African guidelines of good 
manufacturing practice (GMP). A Dura Shock 
Handheld Aneroid sphygmomanometer model 
DS55 was used to measure BP since manual 
sphygmomanometers are said to be more 
accurate than automatic ones.14 Measurements 
were conducted according to standard operating 
procedures.15The sphygmomanometer was 
calibrated, and an obese BP cuff was used for 
overweight participants to ensure reliable 
results. Attempts were made for BP to be 
measured at the same time of day. 
 
Data analysis 
 
Data was analyzed using the following non-
parametric methods: inter-group analysis was 
conducted with the Mann-Whitney U-test; 
intra-group analysis was done using the 
Friedman and the Wilcoxon-Signed Ranks 
tests. 
 
 
 
Results  
 
Forty two participants with resistant 
hypertension were initially recruited using non-
probability sampling into the study. Nine 
participants were excluded from the study due 
to lack of compliance with regards to their 
follow up appointments. The total number of 
participants that completed the study was 33; 18 
participants were in the treatment group and 15 
participants in the placebo group. 
The median systolic blood pressure readings of 
the treatment and placebo groups over the six 
week study are represented by Graph 4.4. The 
median systolic blood pressure at week 1 for the 
treatment group was 146 (IQR = 11), and for the 
placebo group was 150 (IQR = 20). At week 6 
the median systolic blood pressure for the 
treatment group was 135 (IQR = 24) and the 
median for the placebo group was 140 (IQR = 
14). Both groups showed a similar decrease 
over the study period. 
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Figure 1 Median systolic blood pressure values of 
the treatment and placebo groups. 
 
 Figure 2 below represents the Wilcoxon signed 
ranks test results for the follow-up intra-group 
analysis for the systolic blood pressure for both 
the treatment and placebo groups. The 
Bonferroni adjustment was applied, therefore p 
< 0.01 is considered statistically significant. In 
the treatment group statistically significant 
improvement occurred within the first 2 weeks, 
and continued until week 5; whereas the 
placebo group showed no significant 
improvement at any point in time, indicating 
that the improvement was gradual. 
 The median diastolic blood pressure at week 1 
for the treatment group was 90.00 (IQR = 2), 
and the median diastolic blood pressure for the 
placebo group was 90.00 (IQR= 9). At week 6 
the median diastolic blood pressure for the 
treatment group was 84.00 (IQR= 14) and the 
median diastolic blood pressure for the placebo 
group was 90 (IQR= 19). The treatment group 
therefore had a reduction of 6mmHg whereas 
the placebo group showed no change. 
 
 
Figure 2 Median diastolic blood pressure values of 
the treatment group and the placebo groups. 
 
The Wilcoxon signed ranks test results for the 
intra group analysis for the diastolic blood 
pressure over the six week period for both the 
treatment and placebo groups. In the treatment 
group statistically significant improvement 
occurred within the first 2 weeks, and in the 4th 
week; whereas the placebo group showed no 
significant improvement at any point in time.  
However the Mann-Whitney U test results 
indicated that there was no statistically 
significant difference in both the systolic 
diastolic blood pressure readings between the 
two groups at any point in time. This indicates 
that neither group outperformed the other. 
 
Discussion 
 
Non-parametric measures were used to analyse 
the data; the Mann-Whitney U test was used for 
inter-group analysis, and the Friedman and the 
Wilcoxon signed ranks tests were used for 
intra-group analysis. The Shapiro-Wilk test was 
used to assess for normality in distribution of 
variables between the placebo and treatment 
groups. 
The treatment group showed a 11mmHg 
decrease in median systolic blood pressure by 
week six of the study. The major decline was 
observed at week two and continued for the 
next four weeks. The placebo group had a 
steady decline in the median systolic blood 
pressure of 10mmHg over the six week period 
This decline was statistically significant for 
both the groups. Inter-group analysis revealed 
that neither group outperformed the other. The 
homoeopathic complex therefore did not lower 
blood pressure significantly better than the 
placebo. 
The median diastolic blood pressure for the 
treatment group showed a statistically 
significant decline by week six of the study 
dropping by 6 mmHg. The median diastolic 
blood pressure for the placebo group did not 
show any decline by week six. 
The overall inter-group analysis done using the 
Mann-Whitney U test showed a p value greater 
than 0.05, therefore even though there was a 
statistically significant decline in intra-group 
analysis of the diastolic blood pressure of the 
treatment group, the comparison between the 
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groups indicates that the diastolic blood 
pressure decline was not statistically significant 
therefore neither group outperformed the other.     
The study sample consisted of 33 participants 
which is relatively small. Doing a study on a 
small sample results in certain risks such as: 
failing to find the real effect because of 
inadequate statistical power, and not accurately 
reflecting the population from which the study 
sample was drawn from.16 This study was a six-
week study, done on refractory hypertension, 
which is a chronic illness.  Chronic diseases 
affect people longer and it takes many 
adjustment for a patient to get the desired 
outcome. They do not resolve spontaneously 
and complete cure is seldom achieved. 17 
 
Conclusion 
 
Thirty-three participants completed this study. 
Participants in both the groups showed a 
decline in blood pressure over the study period. 
The results indicated that there was no 
statistically significant difference in blood 
pressure readings between the two groups at 
any point in time. Therefore it can be concluded 
that the homoeopathic complex was not more 
effective in lowering both systolic and diastolic 
blood pressure in people who have refractory 
hypertension, however future research should 
consider using a larger sample group and 
extending the duration of the study period.  
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